PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-143.07%
Both yoy net incomes decline, with CSIQ at -102.22%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
5049.33%
D&A growth well above CSIQ's 17.11%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
681.03%
Deferred tax of 681.03% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
-9.62%
Negative yoy SBC while CSIQ is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
11.20%
Less working capital growth vs. CSIQ's 38.95%, indicating potentially more efficient day-to-day cash usage. David Dodd would confirm no negative impact on revenue.
-17.25%
AR is negative yoy while CSIQ is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-92.90%
Negative yoy inventory while CSIQ is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
94.07%
AP growth of 94.07% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
43679.13%
Growth well above CSIQ's 56.81%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-94.60%
Negative yoy while CSIQ is 3164.33%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-39.92%
Negative yoy CFO while CSIQ is 21.03%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
17.37%
Some CapEx rise while CSIQ is negative at -24.52%. John Neff would see competitor possibly building capacity while we hold back expansions.
100.00%
Acquisition growth of 100.00% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
96.24%
Growth well above CSIQ's 82.05%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
15.91%
We have mild expansions while CSIQ is negative at -2.55%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
6800.00%
Debt repayment growth of 6800.00% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
81.20%
Buyback growth of 81.20% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.